Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $4.79 billion. The enterprise value is $3.87 billion.
Important Dates
The last earnings date was Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 71.95 million shares outstanding. The number of shares has increased by 17.82% in one year.
| Current Share Class | 71.95M |
| Shares Outstanding | 71.95M |
| Shares Change (YoY) | +17.82% |
| Shares Change (QoQ) | +8.52% |
| Owned by Insiders (%) | 1.28% |
| Owned by Institutions (%) | 80.88% |
| Float | 47.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 124.23 |
| Forward PS | 103.65 |
| PB Ratio | 5.02 |
| P/TBV Ratio | 5.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 88.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.38, with a Debt / Equity ratio of 0.09.
| Current Ratio | 7.38 |
| Quick Ratio | 7.07 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -968.74 |
Financial Efficiency
Return on equity (ROE) is -32.09% and return on invested capital (ROIC) is -20.41%.
| Return on Equity (ROE) | -32.09% |
| Return on Assets (ROA) | -19.21% |
| Return on Invested Capital (ROIC) | -20.41% |
| Return on Capital Employed (ROCE) | -31.87% |
| Revenue Per Employee | $232,633 |
| Profits Per Employee | -$1.57M |
| Employee Count | 188 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.89% in the last 52 weeks. The beta is 2.29, so KYMR's price volatility has been higher than the market average.
| Beta (5Y) | 2.29 |
| 52-Week Price Change | +41.89% |
| 50-Day Moving Average | 60.95 |
| 200-Day Moving Average | 43.82 |
| Relative Strength Index (RSI) | 59.21 |
| Average Volume (20 Days) | 715,705 |
Short Selling Information
The latest short interest is 8.58 million, so 11.93% of the outstanding shares have been sold short.
| Short Interest | 8.58M |
| Short Previous Month | 8.05M |
| Short % of Shares Out | 11.93% |
| Short % of Float | 18.02% |
| Short Ratio (days to cover) | 12.01 |
Income Statement
In the last 12 months, KYMR had revenue of $43.74 million and -$295.12 million in losses. Loss per share was -$3.60.
| Revenue | 43.74M |
| Gross Profit | -260.82M |
| Operating Income | -328.40M |
| Pretax Income | -295.12M |
| Net Income | -295.12M |
| EBITDA | -321.54M |
| EBIT | -328.40M |
| Loss Per Share | -$3.60 |
Full Income StatementBalance Sheet
The company has $505.68 million in cash and $84.00 million in debt, giving a net cash position of $894.74 million or $12.44 per share.
| Cash & Cash Equivalents | 505.68M |
| Total Debt | 84.00M |
| Net Cash | 894.74M |
| Net Cash Per Share | $12.44 |
| Equity (Book Value) | 946.26M |
| Book Value Per Share | 13.19 |
| Working Capital | 456.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$227.93 million and capital expenditures -$2.28 million, giving a free cash flow of -$230.21 million.
| Operating Cash Flow | -227.93M |
| Capital Expenditures | -2.28M |
| Free Cash Flow | -230.21M |
| FCF Per Share | -$3.20 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -750.89% |
| Pretax Margin | -674.80% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.82% |
| Shareholder Yield | -17.82% |
| Earnings Yield | -6.19% |
| FCF Yield | -4.83% |
Dividend DetailsAnalyst Forecast
The average price target for KYMR is $69.58, which is 4.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $69.58 |
| Price Target Difference | 4.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 21.35% |
| EPS Growth Forecast (5Y) | 3.07% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 8.66 and a Piotroski F-Score of 1.
| Altman Z-Score | 8.66 |
| Piotroski F-Score | 1 |
